Alemtuzumab‐induced halo naevus‐like hypopigmentation – new insights into secondary skin autoimmunity in response to an immune cell‐depleting antibody. (20th July 2020) - Böhm, M.; Kemp, E.H.; Metze, D.; Muresan, A.M.; Neufeld, M.; Luiten, R.M.; Ruck, T.